We are excited to announce our groundbreaking new partnership with CareDx to develop and commercialize AlloID, a powerful infectious disease detection tool that identifies 100+ pathogens and drug resistance in viruses and bacteria critical to organ transplant patients.

Enabling your lab to offer metagenomic testing quickly and efficiently.

Identifying over 50,000 viruses, bacteria, fungi, and parasites, including 6,000 pathogens.

Experience an interactive introduction to the Explify^® Platform where you’ll learn about advancements in clinical metagenomics and the nuances behind the many testing options available in today’s laboratory testing environment.

For Research Use Only. Not for use in diagnostic procedures.

We are proud to collaborate with Illumina and offer the new Respiratory Pathogen ID/AMR Panel (RPIP), which provides comprehensive detection of 200+ respiratory pathogens and 1200+ antimicrobial resistance genes. 

Watch our new Explify Enrichment video about how it’s now possible to perform comprehensive pathogen detection and quantification as well as identify hundreds of genetic markers of antibiotic resistance within a 24-hour turnaround time.

IDbyDNA is supporting two new CME programs offered by Medscape: “A Clinician’s Guide to Making Sense of Metagenomics” and “From Principles to Practice: How Can Metagenomics Inform Patient Care?”

Watch our new Explify Platform video to learn how laboratories can harness the power of clinical metagenomics

For researchers, genomic centers and microbiology labs

A new Explify application for respiratory viruses now provides rapid identification of SARS-CoV-2 based on metagenomic and targeted sequencing data.

Clinical metagenomics enables culture-free, hypothesis-free detection of uropathogens and genetic markers of antibiotic resistance. By coupling the power of lllumina's next-generation sequencing and IDbyDNA's Explify analytics, a streamlined specimen-to-report shotgun workflow can be performed in 24 hours.